You are here: Industry Insights > pricing

News List

Lianluo Smart Limited Announces Pricing of Approximately $3.4 Million Offering prnasia
February 29, 2020
Under the terms of the securities purchase agreement, the Company has agreed to sell 4.9 million Class A Common Shares.
WHO announces support for drug pricing transparency drugs
June 03, 2019
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
GSK and Novartis ‘misled’ consumers, says Federal Court of Australia europeanpharmaceuticalreview
May 21, 2019
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
TV Pharma Ads Now Required to Include Pricing americanpharmaceuticalreview
May 13, 2019
Health and Human Services Secretary Alex Azar has announced the Trump administration has finalized regulations that will require pharmaceutical companies to disclose the list price of medications costing more than $35 for a month’s supply.
Drug costs soaring? Express Scripts says 2018 growth was lowest in 25 years fiercepharma
February 11, 2019
Politicians have been hitting hard at pharma for months and years, using terms such as “skyrocketing,” “astronomical” or “soaring” to describe drug costs.
Vertex’s CF drug gets label extension as pricing row continues pharmaphorum
January 24, 2019
While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug has received a label extension from the European Commission allowing it to be used in younger children.
Never mind last week's hikes. Pharma still puts pricing at the top of its worry list fiercepharma
January 08, 2019
It may not seem as if pharma companies are biting their nails over drug prices. After all, a cohort of drugmakers made headlines last week with an annual round of January hikes. But the issue is on the top of industry worries for 2019, a new report finds.
Never mind last week's hikes. Pharma still puts pricing at the top of its worry list fiercepharma
January 08, 2019
It may not seem as if pharma companies are biting their nails over drug prices. After all, a cohort of drugmakers made headlines last week with an annual round of January hikes. But the issue is on the top of industry worries for 2019, a new report finds.
Novo Nordisk to slash 250 U.S. jobs in the face of ongoing pricing pressure fiercepharma
September 29, 2018
Days after swinging the ax on 400 R&D jobs in China and Denmark, diabetes giant Novo Nordisk is laying off again—this time in the U.S.
Novartis, axing 19% of its workforce, faces big challenges with thinned ranks fiercepharma
September 26, 2018
When Novartis created its business services unit in 2014, creating $3 billion in what the company called “productivity gains” as it reduced the costs associated with its back-office operations.

Previous page 1 2 Next page